Francesca Prignano

4.9k total citations
156 papers, 2.4k citations indexed

About

Francesca Prignano is a scholar working on Immunology, Dermatology and Rheumatology. According to data from OpenAlex, Francesca Prignano has authored 156 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Immunology, 70 papers in Dermatology and 27 papers in Rheumatology. Recurrent topics in Francesca Prignano's work include Psoriasis: Treatment and Pathogenesis (74 papers), Dermatology and Skin Diseases (38 papers) and Autoimmune Bullous Skin Diseases (15 papers). Francesca Prignano is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (74 papers), Dermatology and Skin Diseases (38 papers) and Autoimmune Bullous Skin Diseases (15 papers). Francesca Prignano collaborates with scholars based in Italy, United States and Switzerland. Francesca Prignano's co-authors include Torello Lotti, Federica Ricceri, Leonardo Pescitelli, Gionata Buggiani, Matteo Becatti, Niccolò Taddei, Claudia Fiorillo, Fabrizio Cantini, Piero Campolmi and Paolo Romagnoli and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Experimental Cell Research.

In The Last Decade

Francesca Prignano

145 papers receiving 2.3k citations

Peers

Francesca Prignano
Francesca Prignano
Citations per year, relative to Francesca Prignano Francesca Prignano (= 1×) peers J.L. López‐Estebaranz

Countries citing papers authored by Francesca Prignano

Since Specialization
Citations

This map shows the geographic impact of Francesca Prignano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Prignano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Prignano more than expected).

Fields of papers citing papers by Francesca Prignano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Prignano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Prignano. The network helps show where Francesca Prignano may publish in the future.

Co-authorship network of co-authors of Francesca Prignano

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Prignano. A scholar is included among the top collaborators of Francesca Prignano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Prignano. Francesca Prignano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Magnoni, Cristina, et al.. (2024). Improving hidradenitis suppurativa management: consensus statements from physicians and patients’ perspectives. Archives of Dermatological Research. 316(8). 577–577.
2.
Bernardini, Nicoletta, Martina Burlando, Antonio Costanzo, et al.. (2024). OPT-In; Optimized Patient Treatment Outcomes in Plaque Psoriasis: A 3-Year State-Transition Treatment-Sequencing Model in the Italian Setting. Dermatology and Therapy. 14(5). 1273–1291.
3.
Cesare, Antonella Di, et al.. (2024). Effects on Lipid Profile after One Year of Apremilast Therapy in Patients with Psoriasis: A Monocentric Experience. Life. 14(3). 395–395. 4 indexed citations
4.
Magnano, Michela, Susanna Rossari, Emanuele Trovato, et al.. (2024). Risankizumab in Oncologic Patients With Psoriasis: A Case Series. SHILAP Revista de lepidopterología. 4(2). 558–560. 1 indexed citations
5.
Bellinato, Francesco, Paolo Gisondi, Angelo Valerio Marzano, et al.. (2023). Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study. Vaccines. 11(4). 740–740. 7 indexed citations
6.
Esposti, Luca Degli, Valentina Perrone, Diego Sangiorgi, et al.. (2023). Estimation of patients with psoriasis potentially eligible and currently untreated with biological drugs in Italy. Italian Journal of Dermatology and Venereology. 158(6). 445–451.
7.
Donetti, Elena, et al.. (2023). Th2 Cytokines Affect the Innate Immune Barrier without Impairing the Physical Barrier in a 3D Model of Normal Human Skin. Journal of Clinical Medicine. 12(5). 1941–1941. 3 indexed citations
8.
Moltrasio, Chiara, Elisabetta Botti, Damiano Abeni, et al.. (2023). Clinical Features and Response to Treatment in Elderly Subjects Affected by Hidradenitis Suppurativa: A Cohort Study. Journal of Clinical Medicine. 12(24). 7754–7754. 2 indexed citations
9.
Simone, Clara De, Maria Concetta Fargnoli, Paolo Amerio, et al.. (2021). Risk of infections in psoriasis: assessment and challenges in daily management. Expert Review of Clinical Immunology. 17(11). 1211–1220. 3 indexed citations
10.
Cesare, Antonella Di, et al.. (2020). SB5 adalimumab biosimilar in the treatment of psoriasis and psoriatic arthritis. Dermatologic Therapy. 33(3). e13435–e13435. 12 indexed citations
11.
Marzano, Angelo Valerio, Andrea Chiricozzi, Giuseppe Argenziano, et al.. (2020). Creation of a severity index for hidradenitis suppurativa that includes a validated quality‐of‐life measure: the HIDRAscore. Journal of the European Academy of Dermatology and Venereology. 34(8). 1815–1821. 12 indexed citations
12.
Simone, Clara De, et al.. (2019). Moderate-to-severe psoriasis and pregnancy: impact on fertility, pregnancy outcome and treatment perspectives. Giornale Italiano di Dermatologia e Venereologia. 154(3). 305–314. 23 indexed citations
13.
Stinco, Giuseppe, Nicola Balato, Cinzia Buligan, et al.. (2019). A multicenter retrospective case-control study on Suspension of TNF-inhibitors and Outcomes in Psoriatic patients (STOP study). Giornale Italiano di Dermatologia e Venereologia. 154(4). 392–399. 7 indexed citations
14.
Prignano, Francesca, Federica Ricceri, Benedetta Bianchi, et al.. (2010). Dendritic cells: ultrastructural and immunophenotypical changes upon nb-UVB in vitiligo skin. Archives of Dermatological Research. 303(4). 231–238. 8 indexed citations
15.
Prignano, Francesca, Leonardo Pescitelli, Matteo Becatti, et al.. (2009). Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin. Journal of Dermatological Science. 54(3). 157–167. 55 indexed citations
16.
Prignano, Francesca. (2009). Itch in psoriasis: epidemiology, clinical aspects and treatment options. Clinical Cosmetic and Investigational Dermatology. 2. 9–9. 81 indexed citations
17.
Prignano, Francesca, et al.. (2008). Efalizumab-induced severe thrombocytopenia can be resolved. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Gerlini, Gianni, Alberto Chiarugi, Paola Di Gennaro, et al.. (2008). Induction of CD83+CD14+ Nondendritic Antigen-Presenting Cells by Exposure of Monocytes to IFN-α. The Journal of Immunology. 181(5). 2999–3008. 27 indexed citations
19.
Prignano, Francesca, Leonardo Pescitelli, Federica Ricceri, & Torello Lotti. (2008). The importance of genetical link in immuno‐mediated dermatoses: psoriasis and vitiligo. International Journal of Dermatology. 47(10). 1060–1062. 5 indexed citations
20.
Prignano, Francesca, Christine M. Betts, & Tommaso Lotti. (2007). Vogt-Koyanagi-Harada disease and vitiligo: Where does the illness begin?. Journal of Electron Microscopy. 57(1). 25–31. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026